Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
ACG Case Rep J ; 9(9): e00823, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-36072356

RESUMO

When early-stage esophageal cancer overlies an esophageal varix, endoscopic mucosal resection is not safe because of risk of variceal bleeding. We report a 59-year-old man with alcohol-related liver cirrhosis and an 8 mm Stage I adenocarcinoma in the distal esophagus overlying a large varix. After a multidisciplinary review, we performed band ligation of the nodular adenocarcinoma and varix. On follow-up upper endoscopy 2 months after banding, no evidence of residual adenocarcinoma was visualized. Pathologic biopsies returned negative for malignancy. Band ligation of early-stage esophageal adenocarcinoma may prove an effective option for patients who have nodular malignancies overlying an esophageal varix.

2.
Clin Gastroenterol Hepatol ; 19(8): 1611-1619.e1, 2021 08.
Artigo em Inglês | MEDLINE | ID: mdl-32565290

RESUMO

BACKGROUND & AIMS: Endoscopic submucosal dissection (ESD) is a widely accepted treatment option for superficial gastric neoplasia in Asia, but there are few data on outcomes of gastric ESD from North America. We aimed to evaluate the safety and efficacy of gastric ESD in North America. METHODS: We analyzed data from 347 patients who underwent gastric ESD at 25 centers, from 2010 through 2019. We collected data on patient demographics, lesion characteristics, procedure details and related adverse events, treatment outcomes, local recurrence, and vital status at the last follow up. For the 277 patients with available follow-up data, the median interval between initial ESD and last clinical or endoscopic evaluation was 364 days. The primary endpoint was the rate of en bloc and R0 resection. Secondary outcomes included curative resection, rates of adverse events and recurrence, and gastric cancer-related death. RESULTS: Ninety patients (26%) had low-grade adenomas or dysplasia, 82 patients (24%) had high-grade dysplasia, 139 patients (40%) had early gastric cancer, and 36 patients (10%) had neuroendocrine tumors. Proportions of en bloc and R0 resection for all lesions were 92%/82%, for early gastric cancers were 94%/75%, for adenomas and low-grade dysplasia were 93%/ 92%, for high-grade dysplasia were 89%/ 87%, and for neuroendocrine tumors were 92%/75%. Intraprocedural perforation occurred in 6.6% of patients; 82% of these were treated successfully with endoscopic therapy. Delayed bleeding occurred in 2.6% of patients. No delayed perforation or procedure-related deaths were observed. There were local recurrences in 3.9% of cases; all occurred after non-curative ESD resection. Metachronous lesions were identified in 14 patients (6.9%). One of 277 patients with clinical follow up died of metachronous gastric cancer that occurred 2.5 years after the initial ESD. CONCLUSIONS: ESD is a highly effective treatment for superficial gastric neoplasia and should be considered as a viable option for patients in North America. The risk of local recurrence is low and occurs exclusively after non-curative resection. Careful endoscopic surveillance is necessary to identify and treat metachronous lesions.


Assuntos
Ressecção Endoscópica de Mucosa , Neoplasias Gástricas , Ressecção Endoscópica de Mucosa/efeitos adversos , Mucosa Gástrica/cirurgia , Humanos , Recidiva Local de Neoplasia , Estudos Retrospectivos , Neoplasias Gástricas/cirurgia , Resultado do Tratamento
3.
Obes Surg ; 30(9): 3610-3614, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32279183

RESUMO

Obesity is an important limiting factor for heart transplantation (HT) in patients with congestive heart failure (CHF). Achieving substantial weight loss is challenging in this population due to activity limitations and fluid retention. Endoscopic bariatric therapies (EBTs) including intragastric balloons (IGB) are effective primary weight loss therapies. IGBs have also been successfully utilized as a bridge therapy prior to liver transplantation and, in one case report, prior to HT. Potential advantages of IGBs in this population include low bleeding risk and less invasiveness as compared to other EBTs and surgery. We report the successful use of IGB as a bridge therapy in two patients with class II obesity and end-stage CHF requiring left ventricular assist devices (LVAD), anticoagulation, antiplatelet, and inotrope therapy.


Assuntos
Cirurgia Bariátrica , Balão Gástrico , Transplante de Coração , Obesidade Mórbida , Humanos , Obesidade Mórbida/cirurgia , Redução de Peso
4.
Mayo Clin Proc Innov Qual Outcomes ; 4(1): 105-108, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-32055776

RESUMO

Ingestion of a foreign body is a common occurrence. Flexible endoscopy is most commonly used for treatment, but certain large foreign bodies are more easily retrieved with rigid endoscopy. We present a technically challenging case of intentional ingestion of a large stone that required retrieval from the upper thoracic esophagus using rigid endoscopy. This case highlights the importance of alternative methods to manage large foreign bodies and of collaboration of medical subspecialties.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...